[Long-term survival after treatment of breast cancer thoracic metastases through the association, right from the beginning, of hormonotherapy and non hormonal antineoplastic chemotherapy (author's transl)].
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000732:Androstanols / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000473:pathology; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000473:pathology; D008408:Mastectomy; D008875:Middle Aged; D009277:Nandrolone / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D013899:Thoracic Neoplasms / Q000188:drug therapy / Q000473:pathology
D000732:Androstanols; D000970:Antineoplastic Agents; D004338:Drug Combinations; D009277:Nandrolone
Etude des "long survivants" aprés traitement des métastases thoraciques de cancer du sein par hormonothérapie et chimiothérapie antinéoplasique non-hormonale associées d'emblée.